| Identification | Back Directory | [Name]
H-LYS-LEU-VAL-PHE-PHE-OH | [CAS]
153247-40-6 | [Synonyms]
KLVFF
β-Amyloid (16-20)
LYS-LEU-VAL-PHE-PHE
BETA-AMYLOID (16-20)
H-LYS-LEU-VAL-PHE-PHE-OH
β-Amyloid peptide(16-20)
Amyloid β-Protein (16-20)
AMyloid b-Protein (16-20)
AMYLOID BETA-PROTEIN (16-20)
H-LYS-LEU-VAL-PHE-PHE-OH USP/EP/BP
Amyloid β-Protein (16-20) trifluoroacetate salt
AMYLOID-BETA PROTEIN (16-20), HUMAN, MOUSE, RAT
Amyloid beta-Protein (16-20) trifluoroacetate salt
L-Phenylalanine, L-lysyl-L-leucyl-L-valyl-L-phenylalanyl- | [Molecular Formula]
C35H52N6O6 | [MDL Number]
MFCD00798758 | [MOL File]
153247-40-6.mol | [Molecular Weight]
652.82 |
| Chemical Properties | Back Directory | [Boiling point ]
981.7±65.0 °C(Predicted) | [density ]
1.170±0.06 g/cm3(Predicted) | [storage temp. ]
-15°C
| [form ]
Solid | [pka]
3.50±0.10(Predicted) | [color ]
White to off-white | [Sequence]
H-Lys-Leu-Val-Phe-Phe-OH |
| Hazard Information | Back Directory | [Uses]
β-Amyloid peptide(16-20) is a amino acid sequences (KLVFF) of Amyloid-β (Abeta). β-Amyloid peptide(16-20) is an effective inhibitor of Abeta fibril formation, with RG-/-GR-NH2 residues added at N- and C-terminal ends to aid solubility)[1]. | [References]
[1] Austen BM, et al. Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's beta-amyloid peptide. Biochemistry. 2008 Feb 19;47(7):1984-92. DOI:10.1021/bi701415b |
|
|